President and CEO, Versartis, Inc
Jay Shepard joined the board in May 2018. Jay has served as the President and CEO of Versartis, Inc. since May 2015, and has also served as Executive Chairman of the Versartis Board since early 2014. He previously served as Executive Partner at Sofinnova Ventures, President and CEO of NextWave Pharmaceuticals (acquired by Pfizer), President and CEO of Ilypsa (acquired by Amgen), interim President and CEO of Relypsa (Ilypsa’s spin-out company, which was acquired by Galencia), and Vice President of Commercial Operations at Telik and Alza Pharmaceuticals (acquired by Johnson & Johnson). Jay has over 30 years’ experience in the pharmaceutical, biotechnology and drug delivery arenas, and has participated in or led over 16 product launches by preparing markets and establishing sales and marketing operations. He is a board member of Versartis, Inc., Christopher & Dana Reeve Foundation, and the Santa Clara University Entrepreneurial School. Jay holds a B.S. in business administration from the University of Arizona.